Posted by Michael Wonder on 16 Mar 2022
SK Bioscience submits a rolling review for COVID-19 vaccine 'GBP510' to British pharmaceutical authority
16 March 2022 - SK Bioscience announced today that it has submitted a rolling review document for rapid approval of the COVID-19 vaccine candidate "GBP510" to MHRA, the British pharmaceutical regulatory authority.
SK Bioscience's goal is to go through a sequential review stage with the goal of obtaining a conditional permit in the UK and proceed to the final examination as quickly as possible.
